Edit

KINARUS AG

https://www.kinarus.com/
Last activity: 26.04.2024
KINARUS AG IS A BIOPHARMACEUTICAL COMPANY HEADQUARTERED IN BASEL, SWITZERLAND.
Mentions
23
Employees: 11-50
Total raised: $90.65M
Founded date: 2017
Email

Funding Rounds 3

DateSeriesAmountInvestors
22.08.2022-$20.89M-
13.12.2021Grant$7.57M-
09.09.2021-$62.19M-

Mentions in press and media 23

DateTitleDescriptionSource
26.04.2024Curatis enters SIX Swiss Exchange following the acquisition ...-startuptic...
29.01.2024Kinarus aims to avoid bankruptcy through merger with Curatis Application has been made to the courts of Basel-Stadt to reverse the bankruptcy of Kinarus Therape...startuptic...
25.09.2023Kinarus Therapeutics to file for bankruptcystartuptic...
11.05.2023Kinarus inks convertible loan agreement with Chinese investm...startuptic...
11.05.2023Kinarus Therapeutics signed CHF1.5 million convertible loan ...-globenewsw...
04.11.2022Kinarus Therapeutics Provides Strategic UpdateExploring financial and strategic options to fund Phase 2 trials of KIN001 in wet age-related macula...einpresswi...
30.09.2022Kinarus Therapeutics Announces Discontinuation of the Phase ...KINETIC, a Phase 2 clinical study of KIN001, an oral drug combination, to be discontinued following ...einpresswi...
30.09.2022Kinarus Therapeutics discontinues Phase 2 Kinetic study of K...startuptic...
22.08.2022Kinarus secures CHF20 million to accelerate clinical develop...startuptic...
22.08.2022Kinarus announces the issuance of convertible notes of up to...Financing to be drawn in tranches Financing will enable Kinarus to advance the clinical development ...globenewsw...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In